baber/WOPTO huggingface dataset:
Patent IL-60207-A0 (IL)
Title: Cuvette for the optical examination of liquids
IPC: G01N21/03
Filed: 1980-06-02
Abstract: A cuvette for holding a liquid to be examined optically has front, back, and side walls defining a rectangular cross section and a Y-shaped structure at the bottom thereof for holding the liquid. The Y-shaped structure extends between transparent front and back walls with an upper funnel mouth extending to the side walls, and a liquid holding portion formed of inner walls spaced between the side walls, and extending down to a rounded, tub-shaped bottom. The front walls are transparent and serve also to form the front and back of the liquid holding portion. The bottom preferably has a frustroconic surface to minimize the amount of liquid required for examination and to facilitate mixing of liquids added to the cuvette. The side walls extend below the tub-shaped bottom, and are joined to the front and back wall midway up the liquid holding portion by means of a rib, so that light is not scattered by the side walls and optical inhomogeneities are prevented.
Patent IL-64584-A0 (IL)
Title: 2-acylaminomethyl-1,4-benzodiazepines and salts thereof,their manufacture and pharmaceutical compositions containing them
IPC: A61P25/04
Filed: 1981-12-18
Abstract: Novel 2-acyl amino methyl-5-phenyl-1H-2,3-dihydro-1,4-benzo diazepine compounds of the following Formula I    <IMAGE>  I  which have valuable pharmacological properties are provided. In said Formula I the acyl group -CO-R3 represents a benzoyl group or a phenyl alkanoyl group which may be unsubstituted or mono- or di-substituted in the phenyl ring. The substituent R1 in said compounds indicates lower alkyl, lower alkenyl, or cyclopropyl methyl, and the substituent R2 indicates hydrogen, lower alkyl, or lower alkenyl, while the substituent R6 indicates hydrogen, halogen, lower alkyl, lower alkoxy, hydroxyl, lower alkylthio, nitro, trifluoro methyl, cyano, amino, mono- or di-lower alkyl amino, lower mono-alkanoyl amino, lower N-alkyl-N-alkanoyl amino, or lower alkanoyloxy, and the substituent R7 indicates hydrogen, halogen, lower alkyl, lower alkoxy, hydroxyl, or lower alkanoyloxy, whereby R6 and R7, when attached to adjacent carbon atoms, may form together the methylene dioxy or the ethylene dioxy group. The substituents R8 and R9 designate the same substituents as indicated for the substituents R6 and R7. The compounds of Formula I have a surprising analgesic activity.
Patent IL-70272-A0 (IL)
Title: Acridanone derivatives,their manufacture and pharmaceutical compositions containing them
IPC: A61P33/10
Filed: 1983-11-18
Abstract: Acridanone derivatives of the formula    <IMAGE>  I  wherein the dotted line is an optional bond, R1 is hydrogen, halogen or nitro, R2 is hydrogen or lower alkyl, one of the substituents R3 and R4 is hydrogen or lower alkyl and the other together with R is an additional bond and R5 is hydrogen, lower alkyl, lower alkenyl, lower alkynyl or lower alkyl substituted by halogen or lower alkoxy, and pharmaceutically acceptable acid addition salts thereof, processes for their preparation and pharmaceutical compositions based thereon, are described. The compounds of formula I are useful as schistosomicidal agents.
Patent IL-75356-A0 (IL)
Title: Brazed composite compact implement
IPC: B23K1/00
Filed: 1985-05-31
Abstract: Disclosed is an improved implement comprising a cemented carbide supported composite abrasive compact which is brazed to a cemented carbide substrate with a brazing filler metal having a liquidus substantially above 700 °C. The composite compact preferably is a composite polycrystalline diamond compact. The brazing filler metal is a brazing alloy having a liquidus not substantially above 1,004 °C and which has the following composition, by weight:Au 18-39.5%Ni 3.5-14.5%Pd 2.5-10.5%Mn 7.5-9.0%Cu Balance.
Patent IL-75887-A0 (IL)
Title: Indoloindole derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/48
Filed: 1985-07-23
Abstract: There are disclosed pharmaceutical compounds of the formulain which R' is an aliphatic or aromatic function, and R<sup>2 </sup>and R<sup>3</sup> are each hydrogen, C<sub>1-4</sub> alkyl or a protecting group ; and salts thereof.
Patent IL-83857-A0 (IL)
Title: Modified ceramic structures and methods of making the same
IPC: C04B41/80
Filed: 1987-09-10
Abstract: A method of producing self-supporting ceramic structures (12) comprising (i) a polycrystalline oxidation reaction product formed upon oxidation of a molten parent metal (14) with an oxidant, and (ii) interconnected porosity (13) at least partially accessible from one or more surfaces (15) of said ceramic body. A second polycrystalline ceramic material is incorporated into the porosity of said ceramic body to modify or contribute to its properties.
Patent IL-91708-A0 (IL)
Title: Pipecolic acid-containing peptolides,their preparation and pharmaceutical compositions containing them
IPC: C12N1/14
Filed: 1989-09-21
Abstract: Pipecolic acid-containing peptolides wherein the peptidic backbone is of at least 9  alpha -amino acid residues joined together by peptide bonds, particularly the compounds of formula I <CHEM>  wherein the substituents have various significances, are disclosed. They can be prepared by isolation or derivation from an appropriate microorganism strain such as S 42508/F (NRRL 15761). They have interesting pharmacological, e.g. antifungal, chemotherapeutic drug resistance reversing and to some extent immunosuppressant and antiinflammatory properties.
Patent IL-97187-A0 (IL)
Title: Interface chip device
IPC: G06F13/42
Filed: 1991-02-07
Abstract: An interface chip device, provided for use in a time-division multiplex serial data bus system is operable in a processor interface mode and at least one remote mode wherein the device is capable of directly interfacing with I/O devices. The system does not require software or processing capability for protocol communications or I/O control and, consequently, the communications protocol is transparent to the user, system developer or programmer. The communication protocol of the bus system includes a plurality of commands such that when in the remote mode, the chip device determines the validity of each of the commands and provides an echo response message on the data bus in response to each of the commands except for a broadcast command. The remote modes of the chip device include a remote switch mode, a data input mode, a data output mode or a combination of the remote modes. The chip device is divided into six main functional areas: encoder/decoder, message analyzer, protocol sequencer, data storage, control timers, and input/output controller. The chip device may be used in small remote modules that are located in convenient locations adjacent to the loads they are controlling or switching. The remote modules are controlled by messages from a multiplex data bus controller which are formatted through the communications protocol of the data bus system. The chip device is designed to handle the communications protocol of the data bus system and provide interface between the data bus and other electronic hardware elements.
Patent AU-PO669597-A0 (AU)
Title: Inductive heating method
IPC: A23L3/04
Filed: 1997-05-08
Abstract: A method and apparatus (10) for the heating of convective material contained within the lumen of an inductive heating coil (12, 15, 16, 17) such that the cans (20) are rotated about their axes as they are heated. When the cans (20) are to be heated above the boiling point of their contents the cans (20) are passed through a rotary pressure lock (13, 19, 22) so that the heating of the contents of the cans (20) occurs under a super-atmospheric pressure.
Patent AU-PP807399-A0 (AU)
Title: Improved immunogenic lhrh composition and methods relating thereto
IPC: A61K39/39
Filed: 1999-01-08
Abstract: An immunogenic composition comprises (1) an LHRH-diphtheria toxoid conjugate, and (2) an immunostimulating complex that itself optionally includes an additional protein, but the composition does not contain an ionic polysaccharide as adjuvant. The composition is for use in a method of eliciting in an animal an effective immune response. The immune response may inhibit the reproductive capacity of the animal. 
It is further provided a vaccine against bovine viral diarrhea virus (BVDV) comprising as adjuvant a combination of DEAE-dextran and an immunostimulating complex (ISCOM).
Patent FI-20080277-A0 (FI)
Inventor: HALTTUNEN LASSE
IPC: H04M1/72412
Filed: 2008-04-09
Abstract: The invention is relates to a method where a video film or a multimedia presentation is ordered from an operator or a publisher of a newspaper. The operator sends a film or a multimedia presentation or a newspaper to a mobile phone e.g. via radio broadcasting in a 3G network or via Internet. The video film or multimedia presentation or the newspaper is transferred from the mobile phone by means of Bluetooth connection to a TV accessory that is connected to a TV and which converts the signals so that they are suitable for a TV. This video film or multimedia presentation can thus be watched and heard on TV by means of the mobile phone accessory or a newspaper can be read on the TV screen.
Patent IL-100188-A0 (IL)
Title: Processed cheese preparation
IPC: A23C19/082
Filed: 1991-11-28
Abstract: A novel type of processed cheese preparation is described, composed of cheese, fat, emulsifying salts, water and conventional additives such as emulsifiers, binders, thickeners, curd cheese, milk protein and flavourings in the conventional amounts, trisodium citrate and/or sodium phosphate being used as the emulsifying salts in a quantity of 1.5 - 3% and the mixture containing a modified starch having high amylopectin and low amylose content and/or highly esterified pectin in an amount of 0.25 - 2%.
Patent IL-103005-A0 (IL)
Title: Process for producing pharmaceutical compositions
IPC: A61K9/14
Filed: 1992-08-31
Abstract: PCT No. PCT/EP92/01953 Sec. 371 Date Mar. 4, 1994 Sec. 102(e) Date Mar. 4, 1994 PCT Filed Aug. 25, 1992 PCT Pub. No. WO93/04676 PCT Pub. Date Mar. 18, 1993.A process for the preparation of a pharmaceutical composition in the form of agglomerates comprising 70-97% by weight of 2-(4-isobutylphenyl)propionic acid or a pharmaceutically acceptable salt thereof and 3-30% by weight of a starch component, said process comprising the steps of a) forming an emulsion comprising 1) 70-97% by weight of 2-(4-isobutylphenyl)propionic acid or a salt thereof 2) a solvent system 3) 3-30% by weight of the starch component 4) water and optionally 5) a surfactant b) crystallising to produce a suspension comprising crystals of 2-(4-isobutylphenyl)propionic acid or the salt thereof in intimate contact with the starch component c) agitating said suspension to form agglomerates comprising an evenly distributed mixture of 2-(4-isobutylphenyl)propionic acid or a salt thereof and the starch component d) collecting said agglomerates and optionally e) drying said agglomerates. Pharmaceutical formulations comprising 90-99.98% by weight of such a composition together with 0.02-10% of a pharmaceutically acceptable excipient are also described, which are suitable for direct compression into tablets.
Patent IL-105001-A0 (IL)
Title: Isosteric antiherpes peptide derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07C237/22
Filed: 1993-03-10
Abstract: Disclosed herein are peptide derivatives of the formula A-B-D-CH2CH{CH2C(O)R<1>}C(O)NHCH{CR<2>(R<3>)COOH}C(O)-E wherein A is a terminal group, for example an optionally substituted phenylalkanoyl, and B is a N-methyl amino acid residue; or A and B together form a saturated or unsaturated alkylaminocarbonyl; D is an amino acid residue; R<1> is alkyl, cycloalkyl, a monosubstituted or a disubstituted amino; R<2> is hydrogen or alkyl and R<3> is alkyl, or R<2> is hydrogen and R<3> is phenylalkyl, or R<2> and R<3> are joined to form a cycloalkyl; and E is a terminal unit, for example, an alkylamino or a monovalent amino acid radical such as NHCH(alkyl)C(O)OH. The derivatives are useful for treating herpes infections.
Patent IL-111208-A0 (IL)
Title: Process for the preparation of long-chain alkyl glycosides
IPC: C12P19/44
Filed: 1994-10-09
Abstract: The invention provides a process for the preparation of long-chain alkyl glycosides, comprising reacting a glucose-containing reactant and a C8-C18 fatty alcohol in the presence of a glucosidase and a reaction promoter effective to promote the formation of the alkyl glycoside when the promoter is present in an amount of less than about 50 wt.% of the total reaction mixture.
Patent IL-116696-A0 (IL)
Title: Production of enzymatically active recombinant carboxypeptidase b
IPC: C12N9/48
Filed: 1996-01-08
Abstract: The subject invention provides a method of producing enzymatically active CPB which comprises treating a recombinant cell containing DNA encoding ProCPB, so that the DNA directs expression of the ProCPB, recovering from the cell the ProCPB so expressed, treating the recovered ProCPB under conditions permitting folding of the ProCPB, subjecting the folded ProCPB to enzymatic cleavage to produce enzymatically active CPB and purifying the enzymatically active CPB.
Patent IL-122141-A0 (IL)
Title: Hydroxylamine derivatives their preparation and pharmaceutical compositions containing them
IPC: C07D295/08
Filed: 1996-06-14
Abstract: PCT No. PCT/HU96/00033 Sec. 371 Date May 13, 1998 Sec. 102(e) Date May 13, 1998 PCT Filed Jun. 14, 1996 PCT Pub. No. WO97/00251 PCT Pub. Date Jan. 3, 1997The present invention provides novel hydroxylamine derivatives represented by the general formula: wherein: X is O, -NH, or a group of formula NR', wherein R and R' are independently selected from alkyl, cycloalkyl, phenylalkyl, phenyl optionally substituted with halo, haloalkyl, alkyl, alkoxy or nitro; and a N-containing heterocyclic ring; R1 is H or alkanoyl, R2 is H or hydroxy optionally acylated with alkanoyl, and R3 is a group of the formula -NR4R5 wherein R4 and R5 are independently selected from H, alkyl, and a group of the formula -CO-NH-R wherein R is as defined above, or wherein R4 and R5 when taken together form a 5- to 7-membered heterocyclic ring which may optionally contain one additional hetero atom selected from nitrogen, oxygen and sulfur and which is optionally substituted with alkyl or phenylalkyl. Also provided are pharmaceutically acceptable acid addition salts of the compounds defined above, as well as pharmaceutical compositions containing the compounds or their acid addition salts as active ingredients. The compounds of the invention have been shown to have anti-ischemic effects.
Patent IL-123598-A0 (IL)
Title: A hand holdable manually dispensing mastic container and material therefor
IPC: B65D75/28
Filed: 1996-09-26
Abstract: PCT No. PCT/GB96/02384 Sec. 371 Date Mar. 17, 1998 Sec. 102(e) Date Mar. 17, 1998 PCT Filed Sep. 26, 1996 PCT Pub. No. WO97/11895 PCT Pub. Date Apr. 3, 1997A hand holdable manually dispensing mastic container is made from two sheets of transparent plastics material which are welded together at a seam around the periphery thereof. The container is formed to have a dispensing edge and a filling end which are parallel to one another. The container has a generally elongate shape which diverges from the dispensing edge to a widest dimension, and parallel to the dispensing edge, and then converges to the filling end. Thus, two trapezoidal portions are formed. The volume of the portion closest to dispensing edge is smaller than the volume of the portion closest to the filling end.
Patent IL-134312-A0 (IL)
Title: Preparation of acidified, moist, shelf-stable filled pastas
IPC: A23L7/109
Filed: 1998-06-17
Abstract: A process for the production of a pre-cooked, high moisture, shelf-stable or refrigerated, acidified filled pasta comprising a filling within a dough skin which comprises mixing pasta ingredients together to form a pasta dough, forming the dough into a sheet suitable to form the skin of the filled pasta, encasing a filling having a water activity of less than 0.93 and a pH of above 4.6 within the dough sheet to give a raw filled pasta, cooking the raw filled pasta in acidified water to a pH of above 4.6 to a moisture content of from 55 to 70% by weight, partially drying to achieve a moisture content of from 40 to 55% and a water activity of less than 0.93, and finally packaging the cooked pasta either with heat processing or under modified atmospheric conditions.
Patent IL-135335-A0 (IL)
Title: Method for inhibiting or preventing hormone induced adverse effects and novel pharmaceutical compositions comprising carotenoids
IPC: A61K31/00
Filed: 2000-03-29
Abstract: A method for preventing the adverse effects which may he associated with the administration of at least one hormone to a subject without detectable cancer comprising administering to such subject at least one carotenoid. The method of the instant invention can be utilized to prevent a variety of adverse effects associated with the administration of hormones, including for example, an increased risk for developing cancer. The instantly claimed method prevents such adverse effects without inhibiting the beneficial activity of the hormone. Further provided by the present invention are compositions which are useful for preventing the adverse effects associated with the administration of hormones. The compositions of the instant invention may be in unit dosage form suitable for daily administration to a human.
Patent IL-140116-A0 (IL)
Title: Polymer composition for pipes
IPC: C08L23/04
Filed: 1999-07-01
Abstract: A multimodal polymer composition for pipes is disclosed. The polymer is a multimodal polyethylene with a density of 0.930-0.965 g/cm<3>, an MFR5 of 0.2-1.2 g/10 min, an Mn of 8000-15000, an Mw of 180-330x10<3>, and an Mw/Mn of 20-35, said multimodal polyethylene comprising a low molecular weight (LMW) ethylene homopolymer fraction and a high molecular weight (HMW) ethylene copolymer fraction, said HMW fraction having a lower molecular weight limit of 3500, and a weight ratio of the LMW fraction to the HMW fraction of (35-55):(65:45).
Patent IL-145790-A0 (IL)
Title: Methods and reagents for determining enzyme substrate specificity, and uses related thereto
IPC: C07K5/08
Filed: 2000-04-10
Abstract: The invention provides a method for determining a preferred amino acid sequence motif for an active site an associated substrate specificity subsites of an enzyme. In the method of the invention, an enzyme is contacted with an oriented degenerate peptide library, certain peptides within the library which are substrates for the enzyme are bound by the enzyme, and bound peptide/enzyme complexes are separated from unbound peptides. The bound peptides are released from the enzyme and are sequenced. A preferred amino acid sequence motif for the active site and associated specificity subsites is determined based upon the relative abundance of different amino acids residues at each degenerate position. The invention also provides peptides, peptide analogs, and other small molecules which have a variety of uses and can be derived from the present invention.
Patent IL-155860-A0 (IL)
Title: Rotary wedge scanner
IPC: G02B7/18
Filed: 2003-05-12
Abstract: A scanning system, including a main housing, and at least one optical wedge (12) rotatable about a shaft means (40) located within the main housing (26), wherein a laser beam having an optical axis and incident on the optical wedge (12), is refracted at least once by the wedge; characterized in that the shaft means (40) passes through the center of the at least one wedge (12) and that the optical axis of the incident laser beam is substantially parallel to, but laterally offset from, the shaft means (40).
Patent IL-160671-A0 (IL)
Title: Droplet deposition apparatus
IPC: B41J2/155
Filed: 2002-09-09
Abstract: A hollow cylindrical support for a plurality of flow-through inkjet print heads has two folded wall sections cooperating to define elongate inlet and outlet ink manifolds, one wall section being thermally conducting so as to promote heat transfer along the length of the support, the other wall section being thermally insulating so as to inhibit heat transfer between the inlet and outlet manifolds. The thermally insulating section serves to trap a boundary layer of fluid, for example in a cavity wall or cellular material.
Patent IL-162302-A0 (IL)
Title: Methods for producing hyaluronan ina recombinant host cell
IPC: C12N9/16
Filed: 2002-12-20
Abstract: The present invention relates to methods for producing a hyaluronic acid, comprising: (a) cultivating a Bacillus host cell under conditions suitable for production of the hyaluronic acid, wherein the Bacillus host cell comprises a nucleic acid construct comprising a hyaluronan synthase encoding sequence operably linked to a promoter sequence foreign to the hyaluronan synthase encoding sequence; and (b) recovering the hyaluronic acid from the cultivation medium. The present invention also relates to an isolated nucleic acid sequence encoding a hyaluronan synthase operon comprising a hyaluronan synthase gene and a UDP-glucose 6-dehydrogenase gene, and optionally one or more genes selected from the group consisting of a UDP-glucose pyrophosphorylase gene, UDP-N-acetylglucosamine pyrophosphorylase gene, and glucose-6-phosphate isomerase gene. The present invention also relates to isolated nucleic acid sequences encoding a UDP-glucose 6-dehydrogenase, UDP-glucose pyrophosphorylase, and UDP-N-acetylglucosamine pyrophosphorylase
Patent IL-180532-A0 (IL)
Title: Non-aqueous microelectronic cleaning compositions containing fructose
IPC: C11D11/00
Filed: 2007-01-03
Abstract: Back end photoresist strippers and residue compositions are provided by non-aqueous compositions that are essentially non-corrosive toward copper as well as aluminum and that comprise a polar organic solvent, a hydroxylated amine, and as a corrosion inhibitor fructose.
Patent IL-182547-A0 (IL)
Title: 4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-alkoxy-7-ethynyl-3-quinolinecarbonitriles for the treatment of ischemic injury
Filed: 2007-04-12
Abstract: Compounds of the formula: wherein: R is methyl or ethyl; R' and R'' are independently alkyl of 1 to 3 carbon atoms, or R' and R'', taken together with the nitrogen to which they are attached, can form a 5 or 6 membered saturated ring which may optionally contain an additional heteroatom selected from NR''', O or S(O)<SUB>n</SUB>; n is 0-2; and R''' is hydrogen or alkyl of 1 to 3 carbon atoms, and pharmaceutically acceptable salts thereof, and their use for inhibiting vascular permeability caused by disease, injury or other trauma.
Patent IL-186034-A0 (IL)
Title: Pyrimidine derivatives for use as anticancer agents
Filed: 2007-09-18
Abstract: A compound of formula (I), wherein the substituents are as defined in the text for use in inhibiting insulin-like growth factor 1 receptor activity in a warm blooded animal such as man.
Patent IL-194930-A0 (IL)
Title: Radiation detector
Filed: 2008-10-26
Abstract: An array of feedhorns feeds detected radiation through waveguides to diode-based mixers to produce modulated intermediate frequency (“IF”) signals. The mixers and waveguides are accommodated on a substrate surface and multiple substrates can be layered up to support a two-dimensional array of waveguide openings in a face of a waveguide/mixer block. A feedhorn block is brought into register with this face so that each waveguide opening connects with a feedhorn. An end portion of each feedhorn is drilled into the opening of a respective waveguide. The main feedhorn block and the waveguide/mixer block are then assembled into registration. This method of construction avoids transverse interfaces in the walls of the feedhorns or waveguides just at the point where the transition is made from one to another.